News About: Pharm. Industry


Pharmaceutical companies’ dilemma over relationship with CSOs

While CSOs(contract sales organizations) have frequently been mentioned in the pharmaceutical field, pharmaceutical companies have concerns over CSOs. In the past, pharmaceutical companies used to have a superior sta...

LG Household & Health Care acquires Tai Guk Pharm for KRW 44.6 billion

LG Household & Health Care(CEO Seok-Yong Cha) signed an agreement to acquire 80% shares of Tai Guk Pharm, a dermatological treatment company that is famous for Domina Cream, a freckle treatment, for KRW 44.6 billion. ...

‘Green Light’ on Daewoong Pharmaceutical with Nabota’s USAN registration

Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced a U.S. medical substance name for ‘Nabota,’ a botulinum toxin, was registered as ‘prabotulinumtoxin A.’ The USAN(United States Adopted Names) is one of the interna...

GSK strengthens R&D partnerships for novel drugs with Korean research centers

GSK Korea(CEO/President Yoo-Seok Hong) held a MOU ceremony with Yonsei University College of Medicine Songdang Cancer Center(Director Hyun-Cheol Jung) on the 2nd and announced they will strengthen a mutual cooperation...

‘Custom vs. Compensation,’ issue over Novartis’ rebate trial

The Novartis’ rebate trial has been repeated without any solution to a question if symposiums and publication are just an industrial custom or part of compensation. In the meantime, a newly-added witness has caused c...

Kyung Name Pharm’s ‘Lemona’ climbed up the Great Wall of China

Kyung Nam Pharm announced on the 1st that the company’s Lemona and Lemona C Tab acquired the final approval of registration from the China Food and Drug Administration getting over the THAAD issue. The CFDA’s food an...

Samsung Biologics & Merck’s strategic agreement of manufacturing biologics

A pharmaceutical and chemical company Merck announced on the 2nd the company signed a memorandum of understanding(MOU) to agree on strategically manufacture biologics and develop their manufacturing process with Samsu...

Yuhan Corporation, Green Cross and Hanmi Pharm had ‘decent’ business performance in 3rd quarter

The ‘Top5’ pharmaceutical companies have shown a good condition in sales performance in this year’s 3rd quarter. On the 31st, the ‘Big3’ pharmaceutical companies(Yuhan Corporation, Green Cross and Hanmi Pharm based o...

Can pharma field touch CSOs, still suspicious as ‘Door for Rebates’?

The industry is paying attention to whether CSOs(contract sales organizations) will be investigated as a plan to eradicate illegal rebates, which has continuously suffocated the pharmaceutical industry. In the circum...

Boryung Pharm’s antihypertensive Kanarb family achieves over KRW 5 billion monthly sales

The Boryung Pharm’s ‘Kanarb(generic name: fimasartan) family,’ Korea’s first novel hypertension treatments, achieved KRW 5 billion monthly prescriptions. The Boryung Pharm’s Kanarb family, including 4 drugs, such as ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.